BCL2L1 and colorectal carcinoma: Thymol (100–1000 μM) showed an antiproliferative effect against HCT‐8 CRC cell lines via cell cycle arrest at G0/G1 phase, upregulating pro‐apoptotic p53 expression, suppressing anti‐apoptotic Bcl‐xL expression, activating caspase‐9/3, and OS‐induced apoptosis (Anvarbatcha et al. 2023).